ArticlePrimary care diabetes2017
Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
J Wilding et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it